Text this: Impact of ixazomib-lenalidomide-dexamethasone therapy on overall survival in multiple myeloma patients: Analysis of the emerging-markets subgroup of the TOURMALINE-MM1 trial.

 __   __     ___      ____       ___     _    _   
 \ \\/ //   / _ \\   |  _ \\    / _ \\  | \  / || 
  \   //   / //\ \\  | |_| ||  | / \ || |  \/  || 
  / . \\  |  ___  || | .  //   | \_/ || | .  . || 
 /_//\_\\ |_||  |_|| |_|\_\\    \___//  |_|\/|_|| 
 `-`  --` `-`   `-`  `-` --`    `---`   `-`  `-`